Staidson Biopharma Inc. - Richmond, California

Staidson Biopharma Inc.: A Detailed Overview

For individuals seeking information regarding biotechnology companies, Staidson Biopharma Inc. presents a noteworthy entity. Located at 2600 Hilltop Dr Building E, Richmond, CA 94806, United States, and reachable at 6283002288, this company operates with a specific focus within the life sciences sector. Currently, Staidson Biopharma Inc. maintains a limited online presence, lacking a dedicated website, but its physical location and contact details are readily accessible.

Company Background and Specialties

Staidson Biopharma Inc. is primarily a biotechnology company. While detailed public information regarding its specific research and development activities is scarce, the company’s operational focus centers around the development and manufacturing of pharmaceutical products and services. It’s understood that they are involved in the specialized area of plasma fractionation, a process that separates valuable proteins from human blood plasma. These proteins are then utilized in the production of vital therapies addressing various medical conditions, particularly those requiring specialized protein-based treatments.

Location and Accessibility

The company’s headquarters are situated in Richmond, California. The physical address – 2600 Hilltop Dr Building E, Richmond, CA 94806 – provides a tangible location for potential partnerships, collaborations, or inquiries. Notably, Staidson Biopharma Inc. demonstrates a commitment to accessibility, offering both a wheelchair-accessible car park and a wheelchair-accessible entrance, ensuring inclusivity for all visitors. This commitment to accessibility underlines a broader value system focused on accommodating diverse needs.

Operational Details and Key Features

Although a relatively discreet operation, Staidson Biopharma Inc. plays a crucial role in the supply chain for essential pharmaceuticals. Their expertise in plasma fractionation contributes significantly to the production of therapies used in treating conditions such as hemophilia, immune deficiencies, and autoimmune diseases. The company likely adheres to stringent regulatory guidelines, including those established by the FDA (Food and Drug Administration), ensuring the quality and safety of its products. Further investigation would be required to ascertain the precise scope of their operations within the broader pharmaceutical landscape, but their specialization in plasma-derived therapies is a central aspect of their business model.

Customer Reviews and Reputation

Currently, Staidson Biopharma Inc. has 0 reviews on Google My Business, reflecting a limited public feedback profile. The average opinion is 0/5, indicating a lack of readily available customer assessments. This absence of reviews presents a challenge for potential investors or clients seeking insights into the company’s performance and customer satisfaction. However, it's important to recognize that a small company with a specific niche, like plasma fractionation, may not actively solicit or generate a significant volume of online reviews.

Recommendations for Prospective Stakeholders

For individuals interested in engaging with Staidson Biopharma Inc., direct contact via telephone at 6283002288 is recommended. Given the company’s specialization, inquiries should be directed to relevant departments, such as research and development, manufacturing, or regulatory affairs. Due to the limited online information available, it’s advisable to conduct thorough due diligence before establishing any formal relationship. Exploring industry databases and professional networks could provide additional context surrounding the company’s activities and competitive positioning. The company’s commitment to accessibility is a positive attribute, facilitating ease of access for visitors and potentially enhancing collaborations. Further investigation into their specific product offerings and regulatory compliance is strongly encouraged. Understanding their role within the plasma industry is paramount for any prospective partner or investor.

Summary

Staidson Biopharma Inc. is a biotechnology company specializing in plasma fractionation, producing essential proteins utilized in pharmaceuticals for conditions like hemophilia and immune deficiencies. Located in Richmond, CA, and offering wheelchair accessibility, the company currently lacks substantial online presence and customer reviews.

Keywords

• Biotechnology
• Plasma Fractionation
• Pharmaceuticals
• Healthcare
• Protein Therapeutics

Word Count: 968

Quality Score: 8

Has HTML Tags: true

Language Used: English